| Name | Title | Contact Details |
|---|
Genstar Capital is a leading middle-market private equity firm, investing in high quality companies for over 30 years. Genstar currently has approximately $17 billion in assets under management and is focused on investing in financial services, software, industrial technology, and healthcare. Genstar partners with its management teams and network of strategic advisors to grow and transform its portfolio companies into industry-leading businesses. We operate as one team with a single office in the heart of San Francisco. Our vision is to help build lasting, impactful businesses that will continue to succeed well beyond our ownership.
TrueBridge identifies and invests in high-performing, access-constrained venture capital opportunities that generate premium value for its partners. The firm is recognized for its data-driven approach to investing in both venture funds and venture-backed companies, as well as for its longstanding partnership with Forbes to produce The Midas List, an annual ranking of technology’s top investors. TrueBridge was founded in 2007 by Edwin Poston and Mel Williams, who bring over 30 years of experience as successful private equity investors, entrepreneurs, and transaction advisors. The firm currently manages over $1.8 billion in institutional assets and is a registered investment advisory with the Securities & Exchange Commission.
Cochran Caronia Waller is a Chicago, IL-based company in the Financial Services sector.
TriplePoint Venture Growth BDC Corp. is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. It was formed to expand the venture growth stage business segment of its sponsor, TriplePoint Capital LLC. The Company’s investment objective is to maximize its total return to stockholders primarily in the form of current income and, to a lesser extent, capital appreciation by primarily lending with warrants to venture growth stage companies focused in technology, life sciences and other high growth industries backed by a select group of leading venture capital investors.